MyAverix Finance
US · Healthcare
Heron Therapeuti (HRTX)
Biotechnology
Heron Therapeuti (HRTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HRTX
Heron Therapeuti (HRTX) — FAQ
What is HRTX's P/E ratio?
The price-to-earnings (P/E) ratio for Heron Therapeuti (HRTX) is 18.00 (data as of 2026-03-23).
Does Heron Therapeuti pay a dividend?
Dividend yield is not available in the current snapshot for Heron Therapeuti (HRTX). Check the MyAverix Finance app for the latest dividend data.
What sector is Heron Therapeuti in?
Heron Therapeuti (HRTX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HRTX listed on?
HRTX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.